The project on the development of new sensitive biomarks for early diagnosis and a better classification of neuroendocrine tumours is well established and running accord to plan. The first patients with NETs have been included in a unique clinical trial with an Oncolytic virus that is only killing the tumour cells and respect normal cells. The results so far look very promising. We expect to get specimens from 35 patients.
Collaboration with Make-A-Wish 2016
i4c has collaborated with Make-A-Wish with the aim to help children’s dreams come true. Make-A-Wish is a nonprofit whose mission is to bring illsuion to those children who suffer serious…
see project 
